文献速递结核与非结核分枝杆菌

Xpert TB/LTBI研究用检测活动性与潜伏性结核感染

Evaluating the Cepheid Xpert TB/LTBI Research-Use-Only Assay for Detection of Active and Latent Mycobacterium tuberculosis Infection.
PubMed 文献 · Clin Infect Dis · 2026-01-01

在乌干达和越南≥12岁疑似结核人群中评估Xpert TB/LTBI检测血液9种结核抗原刺激mRNA靶标。识别活动性结核AUC为0.92(95%CI .88-.96),在≥90%灵敏度切点下灵敏度93.5%、特异度76.3%,超过WHO筛查最低准确性目标,但区分活动性与潜伏感染仍需改进。

要点

  • Xpert TB/LTBI识别活动性结核AUC 0.92,灵敏度93.5%、特异度76.3%。
  • 检测超过WHO结核筛查最低准确性目标。
  • 两步算法区分活动性与潜伏结核准确性较低。

核心结论

  • Xpert TB/LTBI超过WHO推荐的结核筛查最低准确性目标。
  • 需进一步改进其区分活动性结核与潜伏感染的能力。

研究设计与样本

  • 在乌干达和越南诊所纳入≥12岁疑似结核个体。
  • 所有参与者接受痰液(液体培养;Xpert MTB/RIF Ultra)和血液(Xpert TB/LTBI;QuantiFERON-TB Gold Plus)检测。
  • 共纳入214人,56.5%为男性,9.3%合并HIV,29.0%为活动性结核,31.8%为潜伏结核感染。

主要发现

  • Xpert TB/LTBI识别活动性结核的AUC为0.92(95%CI .88-.96)。
  • 在达到≥90%灵敏度的切点下,灵敏度93.5%(95%CI 84.6-97.5),特异度76.3%(95%CI 69.0-82.4)。

临床怎么用

  • 可考虑用于疑似结核的血液筛查,但区分活动性与潜伏感染需谨慎解读。

局限性

  • 检测为研究用仅(research-use-only)。
  • 两步算法第二步区分活动性与潜伏结核准确性较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate nonsputum tests are essential for improving tuberculosis (TB) detection. We report the first evaluation of the Xpert TB/LTBI assay (research-use-only; Cepheid, USA), which detects 9 Mycobacterium tuberculosis antigen-stimulated mRNA targets from blood. METHODS: We enrolled individuals ≥12 years with presumptive TB from clinics in Uganda and Vietnam. All participants underwent sputum- (liquid culture; Xpert MTB/RIF Ultra) and blood-based (Xpert TB/LTBI; QuantiFERON-TB Gold Plus [QFT-Plus]) testing. Participants were classified as having active TB (positive sputum results), latent TB infection (LTBI; positive QFT-Plus with negative sputum results), or no TB infection. Diagnostic accuracy for active TB (primary analysis) and of a 2-step algorithm that first predicted TB infection (active TB or LTBI) and then distinguished active TB from LTBI was assessed using logistic regression and receiver operating characteristic analysis. RESULTS: Among 214 participants included, 56.5% were male, 9.3% were with HIV, 29.0% had active TB, and 31.8% had LTBI. Xpert TB/LTBI area under the curve (AUC) was 0.92 (95% CI: .88-.96) for identifying active TB, and sensitivity was 93.5% (95% CI: 84.6-97.5) and specificity 76.3% (95% CI: 69.0-82.4) at a cut-point that achieved ≥90% sensitivity. In the 2-step algorithm, Xpert TB/LTBI had high accuracy for identifying TB infection in the first step, but accuracy was lower for distinguishing active TB from LTBI in the second step. CONCLUSIONS: Xpert TB/LTBI exceeded World Health Organization (WHO)-recommended minimum accuracy targets for a TB screening test. However, further refinement is needed to improve its ability to distinguish active TB from LTBI.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sweetser B, Nguyen H, Dang H, et al. Evaluating the Cepheid Xpert TB/LTBI Research-Use-Only Assay for Detection of Active and Latent Mycobacterium tuberculosis Infection. Clin Infect Dis. 2026. PMID: 41562455. doi:10.1093/cid/ciag005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。